Rome Wasn't Built in a Day. Now, all the aces are on the SPPI hands and it can play them as time allows it.
We are not far away from October when another drug will be added to the poll of SPPI drugs. This new drug will generate a good stream of revenue and income while other drugs in the pipeline get mature.
Basically, there is not enough float left to sell and push PPS down unless some weak hands sell based on panic or big holders who constantly buy and sell push it down based on market direction.
After all, SPPI shares at current prices are desirable by some big guys and they are stealing shares from some retails.
Loaded my 401k with SPPI.
It is a value trapped stock.
It is surrounded by some unreal stories that some people have created without considering many potential for the company and its stock. VRTX was in same situation about 3 years ago. VRTX was in $30s with over $2 B rev, mostly from HEP C until GILD and other companies took HEP C market but VRTX kept developing other drugs. Although VRTX lost HEP C, its pipeline that has not produced yet has push the price over $120.
The same history will be repeated for SPPI. After SPI-2012 phase III, you may not be able to buy SPPI below $70. Mark this post and check it in 2 years.